Literature DB >> 12464929

Novel beta2-adrenergic receptor signaling pathways.

Jeffrey L Benovic1.   

Abstract

The beta(2)-adrenergic receptor (beta(2)AR) is perhaps the most thoroughly investigated of all G-protein-coupled receptors. Although the classical pathway of beta(2)AR signaling involves agonist-promoted binding of the receptor to the heterotrimeric guanosine triphosphate-binding protein G(s), activation of adenylyl cyclase, and production of cyclic adenosine monophosphate (cAMP), current evidence suggests that beta(2)AR signaling is regulated by interaction with multiple proteins. These interactions fall into 3 major groups: guanosine triphosphate-binding proteins such as G(s) and G(i); protein kinases such as the cAMP-dependent protein kinase, protein kinase C, G-protein-coupled receptor kinases, and tyrosine kinases; and adaptor proteins such as arrestins, A-kinase anchoring proteins, and the Na(+)/H(+)-exchanger regulatory factor. This review discusses these various interactions with particular emphasis on their role in regulating beta(2)AR signaling and trafficking.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464929     DOI: 10.1067/mai.2002.129370

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

Review 1.  Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

Authors:  Shoshana Greenberger; Joyce Bischoff
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 2.  Molecular mechanisms of beta2-adrenergic receptor function and regulation.

Authors:  Dennis W McGraw; Stephen B Liggett
Journal:  Proc Am Thorac Soc       Date:  2005

3.  AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease RBCs revealed by force nanoscopy.

Authors:  Jamie L Maciaszek; Biree Andemariam; Krithika Abiraman; George Lykotrafitis
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

4.  Regulation of Active ICAM-4 on Normal and Sickle Cell Disease RBCs via AKAPs Is Revealed by AFM.

Authors:  Jing Zhang; Krithika Abiraman; Sasia-Marie Jones; George Lykotrafitis; Biree Andemariam
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

Review 5.  The outstanding role of miR-132-3p in carcinogenesis of solid tumors.

Authors:  Milad Rafat; Mahta Moraghebi; Masoumeh Afsa; Kianoosh Malekzadeh
Journal:  Hum Cell       Date:  2021-05-17       Impact factor: 4.174

6.  Common genetic variants of the β2-adrenergic receptor affect its translational efficiency and are associated with human longevity.

Authors:  Ling Zhao; Fan Yang; Ke Xu; Huiqing Cao; Gu-Yan Zheng; Yan Zhang; Jianxin Li; Hanbin Cui; Xiaomin Chen; Zhiming Zhu; Hongbo He; Xianming Mo; Brian K Kennedy; Yousin Suh; Yi Zeng; Xiao-Li Tian
Journal:  Aging Cell       Date:  2012-10-11       Impact factor: 9.304

Review 7.  The role of ADRB2 gene polymorphisms in malignancies.

Authors:  Yaqian Wang; Shujuan Jiang
Journal:  Mol Biol Rep       Date:  2021-03-06       Impact factor: 2.316

8.  Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context.

Authors:  Alexander M Kulminski; Irina Culminskaya; Svetlana V Ukraintseva; Konstantin G Arbeev; Kenneth C Land; Anatoli I Yashin
Journal:  Mech Ageing Dev       Date:  2010-04-24       Impact factor: 5.432

9.  Haemodynamic responses to salbutamol and isometric exercise are altered in young adults with mild asthma.

Authors:  W Stephen Waring; Rachel B Leigh
Journal:  Eur J Clin Pharmacol       Date:  2005-01-27       Impact factor: 2.953

10.  Structural Basis of the Activation of Heterotrimeric Gs-Protein by Isoproterenol-Bound β1-Adrenergic Receptor.

Authors:  Minfei Su; Lan Zhu; Yixiao Zhang; Navid Paknejad; Raja Dey; Jianyun Huang; Ming-Yue Lee; Dewight Williams; Kelsey D Jordan; Edward T Eng; Oliver P Ernst; Joel R Meyerson; Richard K Hite; Thomas Walz; Wei Liu; Xin-Yun Huang
Journal:  Mol Cell       Date:  2020-08-19       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.